Desensitization of patients with inflammatory bowel disease to sulfasalazine

This publication has 22 references indexed in Scilit:

• Is Plasma Level Monitoring of Sulfasalazine Indicated in the Treatment of Crohnʼs Disease or Ulcerative Colitis?
  Therapeutic Drug Monitoring, 1980
• Sulfasalazine toxic reactions. Hepatitis, fever, and skin rash with hypocomplementemia and immune complexes
  Published by American Medical Association (AMA) ,1978
• Hemolytic Anemia in Patients Receiving Sulfasalazine
  Digestion, 1978
• Red cell abnormalities associated with sulphasalazine maintenance therapy for ulcerative colitis.
  Gut, 1975
• A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (Salazopyrin)
  Gut, 1973
• The metabolism of salicylazosulphapyridine in ulcerative colitis: I The relationship between metabolites and the response to treatment in inpatients
  Gut, 1973
• CONTROLLED TRIAL OF SULPHASALAZINE IN MAINTENANCE THERAPY FOR ULCERATIVE COLITIS
  The Lancet, 1965
• The Occurrence of Heinz Bodies During Azulfidine Treatment of Ulcerative Colitis
  Digestion, 1963
• HEINZ-BODY ANÆMIA DUE TO SALICYLAZOSULPHAPYRIDINE
  The Lancet, 1958
• The treatment of 124 cases of ulcerative colitis with salazopyrine and attempts of desensibilization in cases of hypersensitiveness to sulfa
  Acta Medica Scandinavica, 1948